Newsroom.

Soleo Health, an innovative national provider of complex specialty pharmacy and infusion services, invited GC Biopharma USA, Inc. to participate in their National Sales Meeting, which was held in Austin, Texas from March 02-05, 2020.

Craig Vollmer, chief commercial officer of Soleo Health, stated: “On behalf of our Soleo Health team, I would like to express our sincere gratitude to GC Biopharma USA, Inc. for their sponsorship of our 2020 National Sales Meeting, along with the many other sponsors. The feedback we received regarding GC Biopharma USA, Inc.’s participation and support was overwhelmingly positive.”

In response, Lisa Betts, chief commercial officer of GC Biopharma USA, Inc., added, “Participating in Soleo Health’s National Meeting was an honor. We will continue to support Soleo Health and the specialty pharmacy industry as we move forward with our launch of IVIG 10% in the US.”

About GC Biopharma USA, Inc.

GC Biopharma USA, Inc., Inc., headquartered in Fort Lee, NJ, established its sales, marketing, and business operations, in 2018, to serve customers and patients throughout the US. Our foundation is built on the expertise of our parent company GC Biopharma, a leading biopharmaceutical company delivering plasma therapies and vaccines throughout the world. With GC Biopharma USA, Inc., GC Biopharma will further extend its footprint, bringing its expertise and legacy to the United States.

This press release may contain forward-looking statements that express the current beliefs and expectations of GC Biopharma USA, Inc.'s management. Such statements do not represent any guarantee by GC Biopharma USA, Inc. or its management of future performance and involve known and unknown risks, uncertainties, and other factors. GC Biopharma USA, Inc. undertakes no obligation to update or revise any forward-looking statement contained in this press release or any other forward-looking statements it may make, except as required by law or stock exchange rule.